Immediate Impact
2 by Nobel laureates 3 from Science/Nature 66 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Prasanna Kumar being referenced
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas
2023
Phase 1 Dose Escalation Study of MDM2 Inhibitor DS-3032b in Patients with Hematological Malignancies - Preliminary Results
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Prasanna Kumar | 178 | 239 | 104 | 151 | 38 | 558 | |
| Hamilto Yamamoto | 156 | 258 | 126 | 94 | 40 | 633 | |
| N Horschowski | 292 | 211 | 53 | 137 | 37 | 647 | |
| Vasilios Panagopoulos | 160 | 134 | 68 | 119 | 31 | 562 | |
| Fumihiro Kimura | 271 | 84 | 173 | 90 | 39 | 620 | |
| Maciej Kinalski | 175 | 93 | 96 | 140 | 26 | 543 | |
| Tomoyo Yasui | 255 | 186 | 74 | 58 | 57 | 605 | |
| É. Frouin | 126 | 215 | 62 | 95 | 51 | 636 | |
| Seisho Sakai | 135 | 185 | 102 | 94 | 44 | 544 | |
| Hui Zhang | 291 | 252 | 73 | 217 | 46 | 633 | |
| Yasuhiro Koikawa | 178 | 160 | 93 | 36 | 22 | 474 |
All Works
Login with ORCID to disown or claim papers
Loading papers...